Regent Pacific Group Limited (HKG:0575)
0.9000
0.00 (0.00%)
At close: Mar 10, 2026
Regent Pacific Group Market Cap
Regent Pacific Group has a market cap or net worth of 262.63 million as of March 10, 2026. Its market cap has increased by 125.43% in one year.
Market Cap
262.63M
Enterprise Value
275.37M
Revenue
6.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.90
Market Cap Chart
Since March 10, 2016, Regent Pacific Group's market cap has decreased from 13.03B to 262.63M, a decrease of -97.98%. That is a compound annual growth rate of -32.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 262.63M | -15.89% |
| Dec 31, 2025 | 312.24M | 274.48% |
| Dec 31, 2024 | 83.38M | -41.12% |
| Dec 29, 2023 | 141.60M | -25.33% |
| Dec 30, 2022 | 189.63M | -48.68% |
| Dec 31, 2021 | 369.51M | -17.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fusen Pharmaceutical Company | 805.84M |
| Pak Fah Yeow International | 732.35M |
| Zhongzhi Pharmaceutical Holdings | 656.34M |
| China NT Pharma Group Company | 492.20M |
| Wai Yuen Tong Medicine Holdings | 376.91M |
| Shenzhen Neptunus Interlong Bio-technique Company | 246.67M |
| Tianda Pharmaceuticals | 215.00M |
| Extrawell Pharmaceutical Holdings | 188.70M |